0.90
price down icon9.09%   -0.09
after-market Dopo l'orario di chiusura: .90
loading

Unity Biotechnology Inc Azioni (UBX) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
1.02%
7.599
7.677 14.58 11.85 10.56
Interest Income/Expense
100.00%
-
0.001 0.566 0.883 1.002
Operating Income/Loss
1.02%
-7.599
-7.677 -14.58 -11.85 -10.56
Income/Loss From Continuing Operations Before Tax
33.41%
-5.79
-4.34 -14.78 -15.46 -5.279
Income/Loss From Continuing Operations After Tax
33.41%
-5.79
-4.34 -14.78 -15.46 -5.279
Net Income/Loss
33.41%
-5.79
-4.34 -14.78 -15.46 -5.279
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
5,034%
16.79
0.3269 14.60 14.43 14.31
Diluted Average Shares
5,034%
16.79
0.3269 14.60 14.43 14.31
Basic Earnings Per Share
41.67%
-0.34
-0.24 -1.01 -1.07 -0.37
Diluted Earnings Per Share
41.67%
-0.34
-0.24 -1.01 -1.07 -0.37
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$60.26
price down icon 10.70%
$69.18
price down icon 5.66%
$17.36
price down icon 8.20%
$31.11
price down icon 2.14%
$88.05
price down icon 4.30%
biotechnology ONC
$238.51
price down icon 9.76%
Capitalizzazione:     |  Volume (24 ore):